These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21591024)

  • 21. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
    Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
    BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
    Antoniou AC; Sinilnikova OM; Simard J; Léoné M; Dumont M; Neuhausen SL; Struewing JP; Stoppa-Lyonnet D; Barjhoux L; Hughes DJ; Coupier I; Belotti M; Lasset C; Bonadona V; Bignon YJ; ; Rebbeck TR; Wagner T; Lynch HT; Domchek SM; Nathanson KL; Garber JE; Weitzel J; Narod SA; Tomlinson G; Olopade OI; Godwin A; Isaacs C; Jakubowska A; Lubinski J; Gronwald J; Górski B; Byrski T; Huzarski T; Peock S; Cook M; Baynes C; Murray A; Rogers M; Daly PA; Dorkins H; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Niederacher D; Deissler H; ; Spurdle AB; Chen X; Waddell N; Cloonan N; ; Kirchhoff T; Offit K; Friedman E; Kaufmann B; Laitman Y; Galore G; Rennert G; Lejbkowicz F; Raskin L; Andrulis IL; Ilyushik E; Ozcelik H; Devilee P; Vreeswijk MP; Greene MH; Prindiville SA; Osorio A; Benitez J; Zikan M; Szabo CI; Kilpivaara O; Nevanlinna H; Hamann U; Durocher F; Arason A; Couch FJ; Easton DF; Chenevix-Trench G;
    Am J Hum Genet; 2007 Dec; 81(6):1186-200. PubMed ID: 17999359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.
    Bianco A; Quaresima B; Pileggi C; Faniello MC; De Lorenzo C; Costanzo F; Pavia M
    PLoS One; 2013; 8(3):e57781. PubMed ID: 23483928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
    Gaudet MM; Kuchenbaecker KB; Vijai J; Klein RJ; Kirchhoff T; McGuffog L; Barrowdale D; Dunning AM; Lee A; Dennis J; Healey S; Dicks E; Soucy P; Sinilnikova OM; Pankratz VS; Wang X; Eldridge RC; Tessier DC; Vincent D; Bacot F; Hogervorst FB; Peock S; Stoppa-Lyonnet D; ; Peterlongo P; Schmutzler RK; Nathanson KL; Piedmonte M; Singer CF; Thomassen M; ; Hansen Tv; Neuhausen SL; Blanco I; Greene MH; Garber J; Weitzel JN; Andrulis IL; Goldgar DE; D'Andrea E; Caldes T; Nevanlinna H; Osorio A; van Rensburg EJ; Arason A; Rennert G; van den Ouweland AM; van der Hout AH; Kets CM; Aalfs CM; Wijnen JT; Ausems MG; ; ; Frost D; Ellis S; Fineberg E; Platte R; Evans DG; Jacobs C; Adlard J; Tischkowitz M; Porteous ME; Damiola F; ; Golmard L; Barjhoux L; Longy M; Belotti M; Ferrer SF; Mazoyer S; Spurdle AB; Manoukian S; Barile M; Genuardi M; Arnold N; Meindl A; Sutter C; Wappenschmidt B; Domchek SM; Pfeiler G; Friedman E; Jensen UB; Robson M; Shah S; Lazaro C; Mai PL; Benitez J; Southey MC; Schmidt MK; Fasching PA; Peto J; Humphreys MK; Wang Q; Michailidou K; Sawyer EJ; Burwinkel B; Guénel P; Bojesen SE; Milne RL; Brenner H; Lochmann M; ; Aittomäki K; Dörk T; Margolin S; Mannermaa A; Lambrechts D; Chang-Claude J; Radice P; Giles GG; Haiman CA; Winqvist R; Devillee P; García-Closas M; Schoof N; Hooning MJ; Cox A; Pharoah PD; Jakubowska A; Orr N; González-Neira A; Pita G; Alonso MR; Hall P; Couch FJ; Simard J; Altshuler D; Easton DF; Chenevix-Trench G; Antoniou AC; Offit K
    PLoS Genet; 2013; 9(3):e1003173. PubMed ID: 23544012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
    Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW;
    Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
    van den Broek AJ; van 't Veer LJ; Hooning MJ; Cornelissen S; Broeks A; Rutgers EJ; Smit VT; Cornelisse CJ; van Beek M; Janssen-Heijnen ML; Seynaeve C; Westenend PJ; Jobsen JJ; Siesling S; Tollenaar RA; van Leeuwen FE; Schmidt MK
    J Clin Oncol; 2016 Feb; 34(5):409-18. PubMed ID: 26700119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer.
    Metcalfe KA; Lubinski J; Gronwald J; Huzarski T; McCuaig J; Lynch HT; Karlan B; Foulkes WD; Singer CF; Neuhausen SL; Senter L; Eisen A; Sun P; Narod SA;
    Clin Genet; 2018 May; 93(5):1063-1068. PubMed ID: 29206279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
    McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
    Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
    Coignard J; Lush M; Beesley J; O'Mara TA; Dennis J; Tyrer JP; Barnes DR; McGuffog L; Leslie G; Bolla MK; Adank MA; Agata S; Ahearn T; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Arnold N; Aronson KJ; Arun BK; Augustinsson A; Azzollini J; Barrowdale D; Baynes C; Becher H; Bermisheva M; Bernstein L; Białkowska K; Blomqvist C; Bojesen SE; Bonanni B; Borg A; Brauch H; Brenner H; Burwinkel B; Buys SS; Caldés T; Caligo MA; Campa D; Carter BD; Castelao JE; Chang-Claude J; Chanock SJ; Chung WK; Claes KBM; Clarke CL; ; ; Collée JM; Conroy DM; Czene K; Daly MB; Devilee P; Diez O; Ding YC; Domchek SM; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Eliassen AH; Engel C; Eriksson M; Evans DG; Fasching PA; Flyger H; Fostira F; Friedman E; Fritschi L; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; Garcia-Barberan V; García-Closas M; García-Sáenz JA; Gaudet MM; Gayther SA; Gehrig A; Georgoulias V; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hart SN; He W; Hogervorst FBL; Hollestelle A; Hopper JL; Horcasitas DJ; Hulick PJ; Hunter DJ; Imyanitov EN; ; ; ; Jager A; Jakubowska A; James PA; Jensen UB; John EM; Jones ME; Kaaks R; Kapoor PM; Karlan BY; Keeman R; Khusnutdinova E; Kiiski JI; Ko YD; Kosma VM; Kraft P; Kurian AW; Laitman Y; Lambrechts D; Le Marchand L; Lester J; Lesueur F; Lindstrom T; Lopez-Fernández A; Loud JT; Luccarini C; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Mebirouk N; Meindl A; Miller A; Milne RL; Montagna M; Nathanson KL; Neuhausen SL; Nevanlinna H; Nielsen FC; O'Brien KM; Olopade OI; Olson JE; Olsson H; Osorio A; Ottini L; Park-Simon TW; Parsons MT; Pedersen IS; Peshkin B; Peterlongo P; Peto J; Pharoah PDP; Phillips KA; Polley EC; Poppe B; Presneau N; Pujana MA; Punie K; Radice P; Rantala J; Rashid MU; Rennert G; Rennert HS; Robson M; Romero A; Rossing M; Saloustros E; Sandler DP; Santella R; Scheuner MT; Schmidt MK; Schmidt G; Scott C; Sharma P; Soucy P; Southey MC; Spinelli JJ; Steinsnyder Z; Stone J; Stoppa-Lyonnet D; Swerdlow A; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Teulé A; Thull DL; Tischkowitz M; Toland AE; Torres D; Trainer AH; Truong T; Tung N; Vachon CM; Vega A; Vijai J; Wang Q; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wolk A; Yadav S; Yang XR; Yannoukakos D; Zheng W; Ziogas A; Zorn KK; Park SK; Thomassen M; Offit K; Schmutzler RK; Couch FJ; Simard J; Chenevix-Trench G; Easton DF; Andrieu N; Antoniou AC
    Nat Commun; 2021 Feb; 12(1):1078. PubMed ID: 33597508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
    Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
    Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
    Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
    Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Salmena L; Lynch HT; Kim-Sing C; Foulkes WD; Ghadirian P; Neuhausen SL; Demsky R; Tung N; Ainsworth P; Senter L; Eisen A; Eng C; Singer C; Ginsburg O; Blum J; Huzarski T; Poll A; Sun P; Narod SA;
    Breast Cancer Res; 2012 Mar; 14(2):R42. PubMed ID: 22405187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Single Nucleotide Polymorphism in miR-146a Gene with Susceptibility to Breast Cancer in the Iranian Female.
    Siasi E; Solimani M
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1585-1593. PubMed ID: 32592352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
    Meindl A; Ditsch N; Kast K; Rhiem K; Schmutzler RK
    Dtsch Arztebl Int; 2011 May; 108(19):323-30. PubMed ID: 21637635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.